|
January 2010
MVP Portfolio Director Jane Larkindale, Ph.D., participated in the “Minding the Gap: Translating Promising Academic Discoveries into Breakthrough Therapeutics” Workshop, Convened by the Leukemia & Lymphoma Society, January 19-20 at the Double Tree Metropolitan Hotel in New York, N.Y.
October 2009
MVP Portfolio Director Jane Larkindale, Ph.D., spoke about MVP at the 8th Annual BIO Investor Forum, October 28-29 at the Palace Hotel in San Francisco.
For information about the event, visit http://investorforum.bio.org/opencms/bif/2009/.
September 2009
MVP Executive Director was the keynote speaker at the 2009 AZBio Awards Dinner on Thursday, Sept. 24 at the Arizona Grand Resort in Phoenix, speaking about the trend toward venture philanthropy by nonprofit organizations with an interest in supporting the development of treatments, diagnostics and cures for specific disease.
Thursday, September 24, at the Arizona Grand Resort in Phoenix.
More information and a list of award categories are at the AZBio Web site www.azbio.org.
May 2009
MVP Portfolio Director Jane Larkindale, Ph.D., presented “MDA Venture Philanthropy: An Introduction” at the Biotechnology Industry Organization International Convention, the largest global event for the biotech industry. The convention covered investments, policy, state initiatives and economic development, and the international marketplace.
Wednesday, May 20, 10 a.m. in Room 312 at the Georgia World Congress Center, Atlanta.
More event information at www.convention.bio.org
MVP's Executive Director was a panelist at the discussion “New Models of Funding” at “Collaborating for Cures: Developing Treatments for the Brain and Nervous System, A NIO Nonprofit Summit,” and was joined by four other nonprofit leaders to talk about how innovative funding mechanisms like venture philanthropy, micro-venture philanthropy and prizes are transforming the funding landscape beyond traditional grant-making.
Monday, May 11, 11 a.m. - 12:30 p.m. at the St. Regis Hotel, San Francisco.
More event information at www.neurotechindustry.org. |
